State of Wisconsin Investment Board’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
65,821
-1,307
-2% -$42.2K 0.01% 1378
2026
Q1
$2.18M Sell
67,128
-887
-1% -$28.5K 0.01% 1375
2025
Q4
$2.39M Buy
68,015
+5,119
+8% +$181K 0.01% 1345
2025
Q3
$1.65M Sell
62,896
-23,394
-27% -$698K ﹤0.01% 1438
2025
Q2
$2.29M Sell
86,290
-17,371
-17% -$457K 0.01% 1244
2025
Q1
$2.5M Buy
103,661
+21,697
+26% +$686K 0.01% 1161
2024
Q4
$3.3M Buy
81,964
+7,234
+10% +$412K 0.01% 1114
2024
Q3
$4.73M Sell
74,730
-8,043
-10% -$472K 0.01% 975
2024
Q2
$4.39M Buy
82,773
+14,163
+21% +$928K 0.01% 990
2024
Q1
$5.63M Sell
68,610
-8,727
-11% -$388K 0.01% 915
2023
Q4
$1.44M Sell
77,337
-13,235
-15% -$173K ﹤0.01% 1304
2023
Q3
$1M Sell
90,572
-105
-0.1% -$1.5K ﹤0.01% 1393
2023
Q2
$1.47M Buy
90,677
+26,980
+42% +$565K ﹤0.01% 1374
2023
Q1
$1.06M Buy
+63,697
New +$658K ﹤0.01% 1458
2021
Q4
Sell
-89,000
Closed -$559K 2217
2021
Q3
$559K Hold
89,000
﹤0.01% 1663
2021
Q2
$533K Hold
89,000
﹤0.01% 1672
2021
Q1
$563K Hold
89,000
﹤0.01% 1561
2020
Q4
$501K Sell
89,000
-11,100
-11% -$67.2K ﹤0.01% 1539
2020
Q3
$583K Sell
100,100
-278,780
-74% -$1.92M ﹤0.01% 1424
2020
Q2
$2.73M Buy
378,880
+12,300
+3% +$81.7K 0.01% 1059
2020
Q1
$1.72M Buy
366,580
+53,019
+17% +$326K 0.01% 1092
2019
Q4
$2.52M Buy
313,561
+216,261
+222% +$1.58M 0.01% 1102
2019
Q3
$669K Buy
97,300
+13,400
+16% +$99.5K ﹤0.01% 1242
2019
Q2
$696K Buy
83,900
+1,800
+2% +$15.4K ﹤0.01% 1241
2019
Q1
$816K Buy
82,100
+28,600
+53% +$239K ﹤0.01% 1218
2018
Q4
$409K Buy
53,500
+6,600
+14% +$78.9K ﹤0.01% 1367
2018
Q3
$817K Hold
46,900
﹤0.01% 1276
2018
Q2
$445K Buy
+46,900
New +$312K ﹤0.01% 1376

Other funds holding VKTX

State of Wisconsin Investment Board's VKTX Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Viking Therapeutics (VKTX) stake by 1.9% in Q2 2026, selling an estimated $42.2K and leaving 65,821 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #1378.

State of Wisconsin Investment Board first reported a position in VKTX in Q2 2018 and has held it in 28 quarters since. The position peaked at $5.63M in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • State of Wisconsin Investment Board held 65,821 shares of Viking Therapeutics worth $2.57M as of Q2 2026.
  • State of Wisconsin Investment Board sold 1,307 Viking Therapeutics shares in Q2 2026, an estimated $42.2K.
  • Viking Therapeutics made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1378 holding.
  • State of Wisconsin Investment Board first reported a position in Viking Therapeutics in Q2 2018 and has held it in 28 quarters since.
  • State of Wisconsin Investment Board's Viking Therapeutics position peaked at $5.63M in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.